However, Jarinova et al. also specifically investigated the relationship between CAD risk variants and different splicing variants of ANRIL and reported that the CAD risk variant was associated with a decreased amount of the same long variant in whole blood cells [21]. This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.